ICCM
Icecure Medical Ltd

2,941
Mkt Cap
$48.06M
Volume
760,195.00
52W High
$1.66
52W Low
$0.56
PE Ratio
-2.54
ICCM Fundamentals
Price
$0.649
Prev Close
$0.6996
Open
$0.6916
50D MA
$0.8687
Beta
0.38
Avg. Volume
2.1M
EPS (Annual)
-$0.2954
P/B
14.48
Rev/Employee
$45,708.33
Loading...
Loading...
News
all
press releases
IceCure Reports Financial & Operational Results for the Nine Months Ended September 30, 2025
IceCure Reports Financial & Operational Results for the Nine Months Ended September 30, 2025 IceCure Reports Financial & Operational Results for the Nine Months Ended September 30, 2025 PR Newswire...
PR Newswire·1d ago
News Placeholder
More News
News Placeholder
IceCure's ProSense Cryoablation System Receives Regulatory Approval in Switzerland for Indications Including Breast, Lung, Liver, and Kidney Cancer
IceCure's ProSense Cryoablation System Receives Regulatory Approval in Switzerland for Indications Including Breast, Lung, Liver, and Kidney Cancer IceCure's ProSense Cryoablation System Receives...
PR Newswire·2d ago
News Placeholder
IceCure Medical Announces Receipt of Nasdaq Minimum Bid Price Notification
IceCure Medical Announces Receipt of Nasdaq Minimum Bid Price Notification IceCure Medical Announces Receipt of Nasdaq Minimum Bid Price Notification PR Newswire CAESAREA, Israel, Nov. 14, 2025...
PR Newswire·6d ago
News Placeholder
IceCure Medical to Report Third Quarter 2025 Financial and Operating Results on November 19, 2025
IceCure Medical to Report Third Quarter 2025 Financial and Operating Results on November 19, 2025 IceCure Medical to Report Third Quarter 2025 Financial and Operating Results on November 19, 2025 PR...
PR Newswire·8d ago
News Placeholder
IceCure Promotes Shay Levav to Chief Operating Officer as Company Ramps up for Increased Commercial Traction
IceCure Promotes Shay Levav to Chief Operating Officer as Company Ramps up for Increased Commercial Traction IceCure Promotes Shay Levav to Chief Operating Officer as Company Ramps up for Increased...
PR Newswire·10d ago
News Placeholder
Viatris (VTRS) Beats Q3 Earnings and Revenue Estimates
Viatris (VTRS) delivered earnings and revenue surprises of +6.35% and +3.09%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·14d ago
News Placeholder
Acadia Healthcare (ACHC) Beats Q3 Earnings and Revenue Estimates
Acadia Healthcare (ACHC) delivered earnings and revenue surprises of +7.46% and +0.37%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·15d ago
News Placeholder
IceCure's ProSense Showcased at TME Fall Summit: "Take the Lead in Breast Cancer Care" Roundtable Highlighting Cryoablation Advances
IceCure's ProSense Showcased at TME Fall Summit: 'Take the Lead in Breast Cancer Care' Roundtable Highlighting Cryoablation Advances IceCure's ProSense Showcased at TME Fall Summit: 'Take the Lead in...
PR Newswire·1mo ago
News Placeholder
IceCure Medical to Attend the 2025 Maxim Growth Summit
IceCure Medical to Attend the 2025 Maxim Growth Summit IceCure Medical to Attend the 2025 Maxim Growth Summit PR Newswire CAESAREA, Israel, Oct. 9, 2025 IceCure recently achieved a significant...
PR Newswire·1mo ago
News Placeholder
ICCM Shares Rise as FDA Clears ProSense for Breast Cancer Treatment
IceCure Medical shares surge after FDA clears ProSense, marking the first minimally invasive breast cancer treatment for women aged 70 and above.
Zacks·2mo ago

Latest ICCM News

View

Advertisement|Remove ads.

Advertisement|Remove ads.